Skip to main content
OpenTrials
Completed

NCT Number: NCT05604664

Clinical Value and Efficacy Index of Lymphadenectomy for Thoracic Escc

The goal of this observational study is to to clarify the focus of lymph node dissection during esophagectomy.. The main question[s] it aims to answer is:

* provide a basis for accurate staging and the relationship between OS and lymph node dissection

Completed

Looking for future studies?

Notify Me

Key information

Sex eligibility

All sexes

Study type

Observational

Primary location

Sichuan Cancer Hospital and Research Institute

Chengdu, Sichuan, 610041, China

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Pathologic findings proved ESCC (8th AJCC/UICC stage T1b-4aN0-3M0)
  • Underwent esophagecomy (two-field or three-field LN dissection)
  • The primary tumor was thoracic ESCC

Exclusion criteria

  • Located outside the thoracic
  • Patients underwent salvage or R1/R2 esophagecomy
  • The number of resected lymph nodes (RLNs) less than 15
  • With neoadjuvant therapy(NT) or salvage chemoradiotherapy(SCRT)

Treatment and study plan

Primary outcomes

  1. 5-year survival rate of lymph nodes metastases (%) in patients

    Time frame: 2010.1.1-2017.12.30

    Surgical data were retrospectively collected

Sponsors and collaborators

Lead sponsor

Yongtao Han

Other

Registry information

Official study title

Clinical Value and Efficacy Index of Lymphadenectomy for Thoracic Esophageal Squamous Cell Carcinoma

Important dates

Study start
2022
Primary completion
2022
Study completion
2022
First posted
Nov 3, 2022
Registry last updated
Nov 4, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.